0001958244-23-000852.txt : 20230608
0001958244-23-000852.hdr.sgml : 20230608
20230608175131
ACCESSION NUMBER: 0001958244-23-000852
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20230608
DATE AS OF CHANGE: 20230608
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: FIBROGEN INC
CENTRAL INDEX KEY: 0000921299
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-36740
FILM NUMBER: 231003179
BUSINESS ADDRESS:
STREET 1: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-978-1200
MAIL ADDRESS:
STREET 1: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ho Maykin
CENTRAL INDEX KEY: 0001646395
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O AGIOS PHARMACEUTICALS, INC.
STREET 2: 88 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
144
1
primary_doc.xml
144
0001646395
XXXXXXXX
LIVE
0000921299
FibroGen, Inc.
001-36740
409 Illinois Street
San Francisco
CA
94158
1-415-978-1200
May-Kin Ho
Director
Common
Goldman Sachs & Co. LLC
200 West Street
New York
NY
10282
8520
151485.6
97582416
06/08/2023
NASD
Common
06/07/2023
Acquired as compensation -- Restricted Stock Units
FGEN
N
8520
06/07/2023
Compensation
Y
The sales of shares set forth herein are made in connection with a selling plan dated 3/3/2023, that is intended to comply with Rule 10b5-1(c).
06/08/2023
03/03/2023
Goldman Sachs & Co. LLC on behalf of May-Kin Ho